|
| Carding and analysis of TCM syndrome of non-small cell lung cancer based on modern medical diagnosis mode |
| Hits 910 Download times 1316 Received:April 26, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2020.10.25 |
| Key Words
non-small cell lung cancer;modern medical diagnosis mode;TCM syndrome |
| Author Name | Affiliation | E-mail | | WANG Yin | Department of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | | | WU Chaoxu | Department of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | | | WANG Yue | Department of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | | | LI Xiaojie | Department of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | | | HOU Li | Department of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | houli1203@126.com。 |
|
| Abstract
|
| Lung cancer is a common malignant tumor of the respiratory tract in China. Its morbidity and mortality account for the first place in malignant tumors in China. With the progress of modern molecular biology research,comprehensive treatment has significantly prolonged the survival time of lung cancer patients. Based on the comprehensive treatment plan of western medicine,the comprehensive treatment of integrated Chinese and Western medicine in China plays an active role in improving the curative effect,enhancing the quality of life,reducing side effects and prolonging the survival period due to the unique syndrome differentiation and holistic view of traditional Chinese medicine. Therefore,the patient's syndrome research under the program which is based on modern medical diagnosis and treatment is particularly important. This article will comb the TCM syndromes of modern medical diagnosis and treatment mode in patients with non-small cell lung cancer (NSCLC),in order to guide the comprehensive treatment of integrated Chinese and Western medicine in the future,so as to better improve the survival and quality of life of patients with NSCLC. |
|
|
|
|
|
|
|
